PEXIDARTINIB

FDA Drug Profile

Drug Details

Generic Name
PEXIDARTINIB
Brand Names
N/A
Application Number
Sponsor
Catalent Pharma Solutions, LLC
NDC Codes
2
Dosage Forms
CAPSULE
Routes
N/A
Active Ingredients
PEXIDARTINIB HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE TURALIO is indicated for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) associated with severe morbidity or functional limitations and not amenable to improvement with surgery. TURALIO is a kinase inhibitor indicated for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) associated with severe morbidity or functional limitations and not amenable to improvement with surgery. ( 1 )